跳至主要内容
临床试验/CTRI/2023/04/051885
CTRI/2023/04/051885尚未招募Unknown

Development of compact device using multispectral Terahertz and Fluorescence Technology for in-situ real time cancer margin detection

Dr Jyotirmayee Dash0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • For Inclusion, an individual must meet all of the following criteria.
  • Inability to meet all inclusion criteria for a cohort will lead to exclusion.
  • 1. Adult males and females, aged 18 years and above
  • 2. Provision of Informed Consent
  • 3. Willing and able to participate in the study and provide tissue samples as per availability and feasibility.
  • 4. No co-morbidities which could impair study participation or sample collection,
  • 5. Female participants: neither pregnant, nor lactating
  • 6. For Study A (Known Cancer Cases)
  • (6a). Diagnosed with any malignancy as per current appropriate Standard of Care approach.
  • (6b). Therapy Naïve as well as received prior anticancer treatments.
  • 7. For Study B (Known Benign Cases)
  • (7a). No prior diagnosis of any cancer.
  • (7b). Confirmed diagnosis of benign (non-cancerous / non-malignant) conditions as per relevant Standard of Care diagnostic work-up.

排除标准

  • For Exclusion, an individual may meet any of the following criteria.
  • Meeting even one exclusion criteria will lead to exclusion.
  • 1. Age less than 18 years,
  • 2. Inability to provide Informed Consent,
  • 3. Failure to meet general or study-specific Inclusion Criteria
  • 4. Pregant and lactating female participants.

研究者

发起方
Dr Jyotirmayee Dash

相似试验